Toshihiro Suzuki

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancers.

T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancers.

Journal: Cancer letters

Published: February 03, 2026

Corrigendum to "Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms" [Vaccine 68 (2025) 127942].

Corrigendum to "Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms" [Vaccine 68 (2025) 127942].

Journal: Vaccine

Published: January 30, 2026

Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms.

Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms.

Journal: Vaccine

Published: September 10, 2025

Comparative analysis of plan quality between two SRS systems for stereotactic irradiation in treating Vestibular Schwannoma.

Comparative analysis of plan quality between two SRS systems for stereotactic irradiation in treating Vestibular Schwannoma.

Journal: Journal of applied clinical medical physics

Published: July 07, 2025

Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases.

Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases.

Journal: International journal of molecular sciences

Published: June 09, 2025

Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr).

Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr).

Journal: Frontiers in oncology

Published: May 22, 2025

Impact of surface functional group modification on cellular internalization and cytotoxicity of silica nanoparticles.

Impact of surface functional group modification on cellular internalization and cytotoxicity of silica nanoparticles.

Journal: Particle and fibre toxicology

Published: March 31, 2025

Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients.

Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients.

Journal: International journal of molecular sciences

Published: January 23, 2025

Delayed Abscopal Response 3 Years After Robotic Stereotactic Body Radiation Therapy for Renal Cell Carcinoma: A Case Report.

Delayed Abscopal Response 3 Years After Robotic Stereotactic Body Radiation Therapy for Renal Cell Carcinoma: A Case Report.

Journal: Cancer reports (Hoboken, N.J.)

Published: December 12, 2024

Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers.

Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers.

Journal: Neoplasia (New York, N.Y.)

Published: December 04, 2024

Stereotactic radiotherapy for metastatic brain tumors: A comparative analysis of dose distributions among VMAT, Helical TomoTherapy, CyberKnife, Gamma Knife, and ZAP-X.

Stereotactic radiotherapy for metastatic brain tumors: A comparative analysis of dose distributions among VMAT, Helical TomoTherapy, CyberKnife, Gamma Knife, and ZAP-X.

Journal: Journal of applied clinical medical physics

Published: November 19, 2024

Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy.

Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy.

Journal: Expert opinion on therapeutic targets

Published: October 21, 2024

Showing 1-12 of 74

Last Updated: 09/26/2026